Comparison of results of a pilot study of alternating vincristine/ doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: A report from the children's oncology group

Carola A.S. Arndt, Douglas S. Hawkins, William H. Meyer, Susan F. Sencer, Joseph P. Neglia, James R. Anderson

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Comparison of results of a pilot study of alternating vincristine/ doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: A report from the children's oncology group'. Together they form a unique fingerprint.

Medicine & Life Sciences